Metabolites of Proton Magnetic Resonance Spectroscopy and Normal Age-Dependent Changes



The goal of this chapter is to introduce the main metabolites of proton MRS with emphasis on developmental changes. Understanding how normal metabolite levels may change in the developing brain is important for the interpretation of MR spectra obtained from children.


White Matter Gray Matter Maple Syrup Urine Disease Brain Stem Glioma Canavan Disease 


  1. 1.
    Kreis R, Hofmann L, Kuhlmann B, Boesch C, Bossi E, Huppi PS. Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med. 2002;48(6):949–58.PubMedCrossRefGoogle Scholar
  2. 2.
    van der Knaap MS, van der Grond J, van Rijen PC, Faber JA, Valk J, Willemse K. Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology. 1990;176(2):509–15.PubMedGoogle Scholar
  3. 3.
    Huppi PS, Posse S, Lazeyras F, Burri R, Bossi E, Herschkowitz N. Magnetic resonance in preterm and term newborns: 1H-spectroscopy in developing human brain. Pediatr Res. 1991;30(6):574–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Toft PB, Leth H, Lou HC, Pryds O, Henriksen O. Metabolite concentrations in the developing brain estimated with proton MR spectroscopy. J Magn Reson Imaging. 1994;4(5):674–80.PubMedCrossRefGoogle Scholar
  5. 5.
    Cady EB, Penrice J, Amess PN, et al. Lactate, N-acetylaspartate, choline and creatine concentrations, and spin-spin relaxation in thalamic and occipito-parietal regions of developing human brain. Magn Reson Med. 1996;36(6):878–86.PubMedCrossRefGoogle Scholar
  6. 6.
    Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med. 1993;30(4):424–37.PubMedCrossRefGoogle Scholar
  7. 7.
    Pouwels PJ, Brockmann K, Kruse B, et al. Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS. Pediatr Res. 1999;46(4):474–85.PubMedCrossRefGoogle Scholar
  8. 8.
    Castillo M, Kwock L, Green C. MELAS syndrome: imaging and proton MR spectroscopic findings. AJNR Am J Neuroradiol. 1995;16(2):233–9.PubMedGoogle Scholar
  9. 9.
    Nanto-Salonen K, Komu M, Lundbom N, et al. Reduced brain creatine in gyrate atrophy of the choroid and retina with hyperornithinemia. Neurology. 1999;53(2):303–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Ross BD, Danielsen ER, Bluml S. Proton magnetic resonance spectroscopy: the new gold standard for diagnosis of clinical and subclinical hepatic encephalopathy? Dig Dis. 1996;14 Suppl 1:30–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Smart JL, Dobbing J, Adlard BP, Lynch A, Sands J. Vulnerability of developing brain: relative effects of growth restriction during the fetal and suckling periods on behavior and brain composition of adult rats. J Nutr. 1973;103(9):1327–38.PubMedGoogle Scholar
  12. 12.
    Lentner C. Geigy scientific tables. In: Ciba G, editor. Units of measurement body fluids nutrition, vol. 1. Ciba-Geigy: Basel, Switzerland; 1981. p. 220. 222, 223.Google Scholar
  13. 13.
    Ernst T, Kreis R, Ross BD. Absolute quantitation of water and metabolites in the human brain. I. Compartments and water. J Magn Reson. 1993;102:1–8.Google Scholar
  14. 14.
    Tallan HH. Studies on the distribution of N-acetyl-L-aspartic acid in brain. J Biol Chem. 1957;224(1):41–5.PubMedGoogle Scholar
  15. 15.
    Baslow MH. Functions of N-acetyl-L-aspartate and N-acetyl-L-aspartylglutamate in the vertebrate brain: role in glial cell-specific signaling. J Neurochem. 2000;75(2):453–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Kreis R, Ernst T, Ross BD. Absolute quantitation of water and metabolites in the human brain. II. Metabolite concentrations. J Magn Reson. 1993;102:9–19.CrossRefGoogle Scholar
  17. 17.
    Brooks WM, Stidley CA, Petropoulos H, et al. Metabolic and cognitive response to human traumatic brain injury: a quantitative proton magnetic resonance study. J Neurotrauma. 2000;17(8):629–40.PubMedCrossRefGoogle Scholar
  18. 18.
    Gasparovic C, Arfai N, Smid N, Feeney DM. Decrease and recovery of N-acetylaspartate/creatine in rat brain remote from focal injury. J Neurotrauma. 2001;18(3):241–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Schuhmann MU, Stiller D, Skardelly M, Thomas S, Samii M, Brinker T. Long-time in-vivo metabolic monitoring following experimental brain contusion using proton magnetic resonance spectroscopy. Acta Neurochir Suppl. 2002;81:209–12.PubMedGoogle Scholar
  20. 20.
    Bluml S, Seymour KJ, Ross BD. Developmental changes in choline- and ethanolamine-containing compounds measured with proton-decoupled (31)P MRS in in vivo human brain. Magn Reson Med. 1999;42(4):643–54.PubMedCrossRefGoogle Scholar
  21. 21.
    Lien YH, Shapiro JI, Chan L. Effects of hypernatremia on organic brain osmoles. J Clin Invest. 1990;85(5):1427–35.PubMedCrossRefGoogle Scholar
  22. 22.
    Panigrahy A, Krieger MD, Gonzalez-Gomez I, et al. Quantitative short echo time 1H-MR spectroscopy of untreated pediatric brain tumors: preoperative diagnosis and characterization. AJNR Am J Neuroradiol. 2006;27(3):560–72.PubMedGoogle Scholar
  23. 23.
    Videen JS. Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study. [see comments.]. J Clin Investig. 1995;95(2):788–93.PubMedCrossRefGoogle Scholar
  24. 24.
    Bitsch A, Bruhn H, Vougioukas V, et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR: Am J Neuroradiol. 1999;20(9):1619–27.PubMedGoogle Scholar
  25. 25.
    Kruse B, Hanefeld F, Christen HJ, et al. Alterations of brain metabolites in metachromatic leukodystrophy as detected by localized proton magnetic resonance spectroscopy in vivo. J Neurol. 1993;241(2):68–74.PubMedCrossRefGoogle Scholar
  26. 26.
    Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993;30(6):672–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Daikhin Y, Yudkoff M. Compartmentation of brain glutamate metabolism in neurons and glia. J Nutr. 2000;130(4S Suppl):1026S–31S.PubMedGoogle Scholar
  28. 28.
    Erecinska M, Silver IA. Metabolism and role of glutamate in mammalian brain. Prog Neurobiol. 1990;35(4):245–96.PubMedCrossRefGoogle Scholar
  29. 29.
    Kreis R. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. [see comments.]. Radiology. 1992;182(1):19–27.PubMedGoogle Scholar
  30. 30.
    Flint AC, Liu X, Kriegstein AR. Nonsynaptic glycine receptor activation during early neocortical development. Neuron. 1998;20(1):43–53.PubMedCrossRefGoogle Scholar
  31. 31.
    Kovanlikaya A, Panigrahy A, Krieger M, et al. Untreated pediatric primitive neuroectodermal tumor in vivo: quantitation of taurine with MR spectroscopy. Radiology. 2005;236(3):1020–5.PubMedCrossRefGoogle Scholar
  32. 32.
    Moreno-Torres A, Martinez-Perez I, Baquero M, et al. Taurine detection by proton magnetic resonance spectroscopy in medulloblastoma: Contribution to noninvasive differential diagnosis with cerebellar astrocytomas. Neurosurgery. 2004;55:824–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Ross BD, Ernst T, Kreis R, et al. 1H MRS in acute traumatic brain injury. J Magn Reson Imaging. 1998;8(4):829–40.PubMedCrossRefGoogle Scholar
  34. 34.
    Holshouser BA, Ashwal S, Luh GY, et al. Proton MR spectroscopy after acute central nervous system injury: outcome prediction in neonates, infants, and children. Radiology. 1997;202(2):487–96.PubMedGoogle Scholar
  35. 35.
    Holshouser BA, Ashwal S, Shu S, Hinshaw Jr DB. Proton MR spectroscopy in children with acute brain injury: comparison of short and long echo time acquisitions. J Magn Reson Imaging. 2000;11(1):9–19.PubMedCrossRefGoogle Scholar
  36. 36.
    Haseler LJ, Arcinue E, Danielsen ER, Bluml S, Ross BD. Evidence from proton magnetic resonance spectroscopy for a metabolic cascade of neuronal damage in shaken baby syndrome. Pediatrics. 1997;99(1):4–14.PubMedCrossRefGoogle Scholar
  37. 37.
    Condon B, Oluoch-Olunya D, Hadley D, Teasdale G, Wagstaff A. Early 1H magnetic resonance spectroscopy of acute head injury: four cases. J Neurotrauma. 1998;15(8):563–71.PubMedCrossRefGoogle Scholar
  38. 38.
    Seymour ZA, Panigrahy A, Finlay JL, Nelson Jr MD, Bluml S. Citrate in pediatric CNS tumors? AJNR Am J Neuroradiol. 2008;29(5):1006–11.PubMedCrossRefGoogle Scholar
  39. 39.
    Costello LC, Franklin RB, Narayan P. Citrate in the diagnosis of prostate cancer. Prostate. 1999;38(3):237–45.PubMedCrossRefGoogle Scholar
  40. 40.
    Gill SS, Thomas DG, Van Bruggen N, et al. Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies. J Comput Assist Tomogr. 1990;14(4):497–504.PubMedCrossRefGoogle Scholar
  41. 41.
    Howe FA, Barton SJ, Cudlip SA, et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med. 2003;49(2):223–32.PubMedCrossRefGoogle Scholar
  42. 42.
    Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed. 2000;13(3):129–53.PubMedCrossRefGoogle Scholar
  43. 43.
    Davies NP, Wilson M, Natarajan K, et al. Non-invasive detection of glycine as a biomarker of malignancy in childhood brain tumours using in-vivo 1H MRS at 1.5 tesla confirmed by ex-vivo high-resolution magic-angle spinning NMR. NMR Biomed. 2010;23(1):80–7.PubMedCrossRefGoogle Scholar
  44. 44.
    Carapella CM, Carpinelli G, Knijn A, Raus L, Caroli F, Podo F. Potential role of in vitro 1H magnetic resonance spectroscopy in the definition of malignancy grading of human neuroepithelial brain tumours. Acta Neurochir Suppl. 1997;68:127–32.PubMedGoogle Scholar
  45. 45.
    Lehnhardt FG, Röhn G, Ernestus RI, Grüne M, Hoehn M. 1H- and (31)P-MR spectroscopy of primary and recurrent human brain tumors in vitro: malignancy-characteristic profiles of water soluble and lipophilic spectral components. NMR Biomed. 2001;14(5):307–17.PubMedCrossRefGoogle Scholar
  46. 46.
    Lehnhardt FG, Bock C, Röhn G, Ernestus RI, Hoehn M. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation. NMR Biomed. 2005;18(6):371–82.PubMedCrossRefGoogle Scholar
  47. 47.
    Seymour KJ, Bluml S, Sutherling J, Sutherling W, Ross BD. Identification of cerebral acetone by 1H-MRS in patients with epilepsy controlled by ketogenic diet. Magma. 1999;8(1):33–42.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2013

Authors and Affiliations

  1. 1.Department of Radiology, Children’s Hospital Los Angeles, Keck School of MedicineUniversity of Southern CaliforniaLos AngelesUSA

Personalised recommendations